Stryker Co. (NYSE:SYK) Shares Purchased by Fishman Jay A Ltd. MI

Fishman Jay A Ltd. MI raised its holdings in Stryker Co. (NYSE:SYK) by 0.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 80,627 shares of the medical technology company’s stock after buying an additional 50 shares during the period. Stryker makes up about 2.7% of Fishman Jay A Ltd. MI’s portfolio, making the stock its 11th biggest holding. Fishman Jay A Ltd. MI’s holdings in Stryker were worth $29,030,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Dunhill Financial LLC grew its stake in Stryker by 94.9% in the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 37 shares in the last quarter. Darwin Wealth Management LLC bought a new position in Stryker during the 3rd quarter worth approximately $36,000. Activest Wealth Management acquired a new position in shares of Stryker in the 4th quarter worth approximately $36,000. Crews Bank & Trust bought a new stake in shares of Stryker in the 4th quarter valued at approximately $39,000. Finally, Hara Capital LLC acquired a new stake in shares of Stryker during the 3rd quarter valued at approximately $42,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Ronda E. Stryker sold 201,392 shares of the firm’s stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the completion of the transaction, the director now owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. This trade represents a 5.24 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 5.90% of the stock is owned by insiders.

Analysts Set New Price Targets

SYK has been the subject of several recent research reports. Robert W. Baird boosted their target price on shares of Stryker from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Needham & Company LLC reiterated a “buy” rating and set a $442.00 price objective on shares of Stryker in a research note on Wednesday, January 29th. Citigroup raised their target price on shares of Stryker from $411.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. The Goldman Sachs Group upped their target price on Stryker from $384.00 to $427.00 and gave the company a “neutral” rating in a report on Thursday, January 30th. Finally, Truist Financial raised their price target on Stryker from $409.00 to $413.00 and gave the stock a “hold” rating in a report on Thursday, January 30th. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $420.68.

Stryker Stock Performance

SYK stock opened at $390.52 on Wednesday. The company has a market capitalization of $148.88 billion, a P/E ratio of 50.33, a PEG ratio of 2.98 and a beta of 0.96. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The company has a 50-day simple moving average of $377.28 and a 200 day simple moving average of $365.59. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping analysts’ consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same period last year, the company posted $3.46 earnings per share. Sell-side analysts predict that Stryker Co. will post 13.49 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend is Monday, March 31st. Stryker’s payout ratio is currently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.